Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|November 28, 2024
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancerSantiago Panesso-Gómez, Alexander J Cole, Alyssa Wield, et al.Biorxiv : the Preprint Server for Biology|March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinomaNilgun Tasdemir, Laura Savariau, Julie Scott, et al.Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck CancerRose Doerfler, Jie Chen, Carl Kim, et al.Oral Oncology|November 10, 2025
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancerRose Doerfler, Jie Chen, Carl Kim, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older womenNeil Carleton, Sanghoon Lee, Ruxuan Li, et al.Nature Aging|July 27, 2026
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older womenNeil Carleton, Alexander Chih-Chieh Chang, Sanghoon Lee, et al.Cancer Letters|March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancerSantiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.Cancer Cell|April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progressionTriet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.Cancer Cell|May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentationPierre Foidart, Zheqi Li, Xinran Cai, et al.Pageof 12